CKD G4-G5D期椎体骨折管理共识声明
该共识声明聚焦CKD G4-G5D期患者的骨骼脆性管理,尤其关注椎体骨折。椎体骨折预示骨折风险增加,在晚期CKD中与主动脉及髂血管钙化和心血管事件强相关。全文从诊断到治疗全面讨论管理策略。
要点
- CKD患者髋部骨折风险为普通人群两倍,椎体骨折研究更少。
- 椎体骨折预示骨折风险增加,晚期CKD中与血管钙化及心血管事件强相关。
- 共识涵盖CKD G4-G5D期骨骼脆性从诊断到治疗的全程管理。
核心结论
- 共识全面讨论CKD患者骨骼脆性管理,重点为G4-G5D期椎体骨折。
研究设计与样本
- 制定机构与方法:原文未报告。
主要发现
- CKD患者髋部骨折风险为普通人群两倍。
- 椎体骨折预示骨折风险增加,晚期CKD中与主动脉及髂血管钙化和心肌梗死等心血管事件强相关。
关键数值与推荐
- 推荐条款:原文未报告。
临床怎么用
- 肾内科医生应关注CKD G4-G5D期患者椎体骨折风险及血管钙化评估。
局限性
- 原文未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Skeletal fragility has long been overlooked by the nephrology community despite patients with chronic kidney disease (CKD) facing double the risk of hip fracture compared with the general population. Consequently, the term CKD-associated osteoporosis was recently coined to increase awareness. In this context, vertebral fractures are even less studied. Vertebral fractures predict increased fracture risk, and especially in advanced CKD, show a strong association with aortic and iliac vascular calcifications and cardiovascular events such as myocardial infarction. The scope of the present consensus paper is to comprehensively discuss the management of skeletal fragility in CKD patients, from diagnosis to treatment, with a particular focus on vertebral fractures in CKD G4-G5D.
引用
- Fusaro M, Chandran M, Nickolas T, et al. A consensus statement on the management of vertebral fractures in CKD stages G4-G5D. Nephrol Dial Transplant. 2026. PMID: 41313307. doi:10.1093/ndt/gfaf256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。